162 related articles for article (PubMed ID: 4419386)
1. Proceedings: Hormones and the prostate.
Griffiths K
Br J Cancer; 1974 Aug; 30(2):187-8. PubMed ID: 4419386
[TBL] [Abstract][Full Text] [Related]
2. Hypophysectomy in the treatment of disseminated carcinoma of the breast and prostate gland.
Tindall GT; Ambrose SS; Christy JH; Patton JM
South Med J; 1976 May; 69(5):579-83. PubMed ID: 1273614
[TBL] [Abstract][Full Text] [Related]
3. Effects of hypophysectomy and prolactin replacement therapy on prostatic response to androgen in orchiectomized rats.
Slaunwhite WR; Sharma M
Biol Reprod; 1977 Nov; 17(4):489-92. PubMed ID: 922084
[TBL] [Abstract][Full Text] [Related]
4. [HORMONAL THERAPY OF BREAST AND PROSTATIC CARCINOMA].
MARTZ G
Med Klin; 1963 Nov; 58():1964-7. PubMed ID: 14095401
[No Abstract] [Full Text] [Related]
5. [The influence of counter-sexual hormone therapy and castration on hemoglobin and rapidity of sedimentation of the blood corpuscles in prostata carcinoma (author's transl)].
Feustel A; Nietzschmann U
Urol Int; 1974; 29(1):1-22. PubMed ID: 4450285
[TBL] [Abstract][Full Text] [Related]
6. The effects of orchidectomy, estrogens, and cyproterone acetate on plasma testosterone, LH, and FSH concentrations in patients with carcinoma of the prostate.
Varenhorst E; Wallentin L; Carlström K
Scand J Urol Nephrol; 1982; 16(1):31-6. PubMed ID: 6211762
[TBL] [Abstract][Full Text] [Related]
7. Effect of a new LH-RH analogue (D-Ser(TBU)6-EA10-LH-RH) on gonadotrophin and gonadal steroid secretion in men.
Wiegelmann W; Solbach HG; Kley HK; Nieschlag E; Rudorff KH; Krüskemper HL
Horm Res; 1976; 7(1):1-10. PubMed ID: 793974
[TBL] [Abstract][Full Text] [Related]
8. [The endocrine profile in prostatic cancer: therapeutic implications].
Calvo Mateo MA; Castellanos Llorens JM; Galán Ortega A
Actas Urol Esp; 1981; 5(1):3-12. PubMed ID: 7015803
[No Abstract] [Full Text] [Related]
9. Physiologic basis for hormonal theapy in carcinoma of the prostate.
Walsh PC
Urol Clin North Am; 1975 Feb; 2(1):125-40. PubMed ID: 48206
[No Abstract] [Full Text] [Related]
10. Proceedings: Clinical value of predictive tests for advanced breast cancer.
Engelsman E
Br J Cancer; 1974 Aug; 30(2):189-90. PubMed ID: 4370884
[TBL] [Abstract][Full Text] [Related]
11. Serum prolactin and tumors of the prostate: unchanged basal levels and lack of correlation to serum testosterone.
Jacobi GH; Rathgen GH; Altwein JE
J Endocrinol Invest; 1980; 3(1):15-8. PubMed ID: 6154729
[TBL] [Abstract][Full Text] [Related]
12. Effects of total and subcapsular orchidectomy on serum concentrations of testosterone and pituitary hormones in patients with carcinoma of the prostate.
Bergman B; Damber JE; Tomić R
Urol Int; 1982; 37(2):139-44. PubMed ID: 6810527
[TBL] [Abstract][Full Text] [Related]
13. Binding capacity of testosterone-estradiol-binding globulin (TeBG), total and calculated unbound concentrations of testosterone in patients with carcinoma of the prostate treated with orchidectomy or estrogens.
Damber JE; Bergman B; Södergård R; Tomić R
J Endocrinol Invest; 1983 Apr; 6(2):91-4. PubMed ID: 6683289
[TBL] [Abstract][Full Text] [Related]
14. Hormonal pattern in prostatic carcinoma following orchidectomy: 5-year follow-up.
Bracci U; Di Silverio F; Sciarra F; Sorcini G; Piro C; Santoro F
Br J Urol; 1977 Apr; 49(2):161-6. PubMed ID: 870137
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of estrogen-resistant forms of cancer of the prostate].
Marinbakh EB; Ar'e VM
Urol Nefrol (Mosk); 1974; 39(4):68-74. PubMed ID: 4606039
[No Abstract] [Full Text] [Related]
16. Effect of orchidectomy performed after cessation of estrogen therapy on serum testosterone concentrations in patients with prostatic carcinoma.
Tomić R; Damber JE
Urol Int; 1987; 42(6):441-4. PubMed ID: 3129850
[TBL] [Abstract][Full Text] [Related]
17. Alterations of peripheral testosterone matabolism after induced hypoprolactinemia in patients with prostatic carcinoma.
Jacobi GH; Altwein JE; Hohenfellner R
Klin Wochenschr; 1979 Jan; 57(1):49-51. PubMed ID: 759717
[TBL] [Abstract][Full Text] [Related]
18. Carcinoma of the prostate: early endocrine therapy is best.
Spirnak JP; Resnick MI
Semin Urol; 1983 Nov; 1(4):269-79. PubMed ID: 6399613
[No Abstract] [Full Text] [Related]
19. Prolactin and breast carcinoma.
Smithline F; Sherman L; Kolodny D
N Engl J Med; 1975 Apr; 292(15):784-92. PubMed ID: 1089886
[TBL] [Abstract][Full Text] [Related]
20. Serum levels of follicle stimulating hormone, luteinizing hormone, prolactin, testosterone, 5 alpha-dihydrotestosterone, 5 alpha-androstane-3 alpha, 17 beta-diol, 5 alpha-androstane-3 beta, 17 beta-diol, and 17 beta-estradiol from male beagles with spontaneous or induced benign prostatic hyperplasia.
Cochran RC; Ewing LL; Niswender GD
Invest Urol; 1981 Nov; 19(3):142-7. PubMed ID: 6170603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
